e-Brochure

PDF version of Haemoglobinopathy  MSc

Contact details

Dr Jitlekha Teerajarmorn

Email: Msc_haemoglobinopathy@ucl.ac.uk

Tel: +44 (0)20 7679 6582

Fees and funding

UK/EU 2013/14:

£8,250 (FT)

Overseas 2013/14:

£18,500 (FT)

Many students study our distance learning programmes to develop their careers and find that their employers are keen to support them, either financially or by providing study leave.

Full details of funding opportunities can be found on the UCL Scholarships website

More information

Prospectus Entry

Women's Health

Key facts

Research Assessment Rating

70% rated 4* (world-leading) or 3* (internationally excellent)
(What is the RAE?)

The programme information on this page relates to 2013 entry. 2014 content to appear here shortly. 

Haemoglobinopathy MSc

The Haemoglobinopathy MSc at UCL, in conjunction with Thalassaemia International Federation, offers the first academic course ever to health professionals in haemoglobinopathies. The programme provides a thorough understanding of holistic care to all aspects of haemoglobinopathy, developing a strong basis for a high-level career in this field.

Degree summary

What will I learn?

The programme equips students with the tools to manage all aspects of haemoglobinopathy, focusing on a global perspective of health. Students gain knowledge of prevention and holistic care of thalassaemia and sickle cell disease and develop basic and clinical science skills alongside an awareness of future developments in the field.

Why should I study this degree at UCL?

The UCL Institute for Women's Health aims to provide an academic environment in which students can develop and pursue research at the highest level of accomplishment.

The institute brings together individuals with expertise across the whole spectrum of women's health – from laboratory science to clinical skills to social and behavioural sciences – with the objective of making a major contribution to the health of women by pioneering research, education programmes and clinical initiatives.

Students on this unique programme are offered the opportunity to pursue a specialist qualification from a leading university with minimum disruption to professional and personal lives. The programme directors (Dr Chatterjee and Dr Bajoria) won a Provost's Teaching Award for excellence in teaching in 2010.

See subject website for more information:

Degree structure

Availability: Full-time 1 year (in attendance at UCL or distance learning); Part-time 2 years (distance learning only)

Students undertake modules to the value of 180 credits. The programme consists of four core modules (105 credits), one optional module (15 credits) and a research project (60 credits).

Core Modules

  • Basic Science, Screening, Prevention and Prenatal Diagnosis
  • Clinical Sciences Related to Thalassaemia
  • Clinical Sciences Related to Sickle Cell Disease
  • Endocrinology

Options

  • Advances in the Field of Haemoglobinopathy
  • Infections in Haemoglobinopathy

Dissertation/report

All MSc students undertake an independent research project which culminates in a dissertation.

Teaching and Learning

All lectures will be delivered as video with interactive and self assessment elements. In addition, each distance-learning module will entail weekly discussion forum, journal club and "meet the expert" session by video conferencing. Assessment is through structured essays, and online examination at the end of each module; unseen examination and the dissertation viva at the end of the programme.

Further details available on subject website:

Entry and application

Entry requirements

A minimum of an upper second-class Bachelor's degree in a relevant discipline, or a medical qualification (MBBS) from a UK university or an overseas qualification of an equivalent standard.

Specialist nurses working in this field who do not have a recognised Bachelor's degree must contact the programme administrator.

Background knowledge in haemoglobinopathy is essential.

For overseas equivalencies see the relevant country page.

How to apply

You may choose to apply online or download application materials; for details visit www.ucl.ac.uk/gradapps

The deadline for applications is late June for the year of entry. Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.

Who can apply?

The programme is designed to appeal to: medical graduates interested in haemoglobinopathy (physicians, paediatrician, haematologist, clinical geneticist, endocrinologist, obstetrician and gynaecologist); science graduates interested in medical research related to haemoglobinopathy and genetics; healthcare professionals interested in haemoglobinopathy (counsellors, clinical psychologists, and nurse specialists and midwives).

What are we looking for?

When we assess your application we would like to learn:

  • why you want to study Haemoglobinopathy at graduate level
  • why you want to study Haemoglobinopathy at UCL
  • what particularly attracts you to the chosen programme
  • how your academic and professional background meets the demands of this programme
  • where you would like to go professionally with your degree
Together with essential academic requirements, the personal statement is your opportunity to illustrate whether your reasons for applying to this programme match what the programme will deliver.

Career

This postgraduate qualification from UCL is career-changing. It can be the springboard to promotion with your current employer, the platform from which to launch a new career or to simply become more effective in your current role. In addition to the academic knowledge, you will develop additional cognitive, team, communication, research, ICT, numeracy and project planning skills that are eminently transferable within the job sector.

Find out more about London graduates' careers by visiting the Careers Group (University of London) website:


Request content update l Request printed information l Disclaimer
Page maintained by Publications and Marketing Services